NFKB1 and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease research, studies have shown that gastrodin reduces neuroinflammatory responses and microglial overactivation in the central nervous system of AD models by regulating the TLR4/TRAF6/NF-κB pathway, thereby contributing to its therapeutic effects against AD (Wang et al., 2024a).